Mundipharma Medical Company
- D02 - Emolientes y protectores
- HIMA-PASTA cutaneous paste 1%+20%
- H02 - Corticosteroides para uso sistémico
- LODOTRA prolonged-release tablet 1 mg
- LODOTRA prolonged-release tablet 2 mg
- LODOTRA prolonged-release tablet 5 mg
- N02 - Analgésicos
- MST CONTINUS prolonged-release granules 100 mg
- MST CONTINUS prolonged-release granules 20 mg
- MST CONTINUS prolonged-release granules 200 mg
- MST CONTINUS prolonged-release granules 30 mg
- MST CONTINUS prolonged-release granules 60 mg
- MST CONTINUS prolonged-release tablet 10 mg
- MST CONTINUS prolonged-release tablet 100 mg
- MST CONTINUS prolonged-release tablet 200 mg
- MST CONTINUS prolonged-release tablet 30 mg
- MST CONTINUS prolonged-release tablet 60 mg
- OXYCONTIN prolonged-release tablet 10 mg
- OXYCONTIN prolonged-release tablet 20 mg
- OXYCONTIN prolonged-release tablet 40 mg
- OXYCONTIN prolonged-release tablet 5 mg
- OXYCONTIN prolonged-release tablet 80 mg
- OXYNORM capsule, hard 10 mg
- OXYNORM capsule, hard 20 mg
- OXYNORM capsule, hard 5 mg
- OXYNORM oral drops, solution 1%
- OXYNORM orodispersible tablet 10 mg
- OXYNORM orodispersible tablet 5 mg
- PALLADON capsule, hard 1.3 mg
- PALLADON capsule, hard 2.6 mg
- PALLADON prolonged-release capsule, hard 16 mg
- PALLADON prolonged-release capsule, hard 24 mg
- PALLADON prolonged-release capsule, hard 4 mg
- PALLADON prolonged-release capsule, hard 8 mg
- PALLADON solution for injection 10 mg/ml
- PALLADON solution for injection 2 mg/ml
- PALLADON solution for injection 20 mg/ml
- PALLADON solution for injection 50 mg/ml
- SEVREDOL film-coated tablet 10 mg
- SEVREDOL film-coated tablet 20 mg
- SEVRE-LONG prolonged-release capsule, hard 120 mg
- SEVRE-LONG prolonged-release capsule, hard 200 mg
- SEVRE-LONG prolonged-release capsule, hard 30 mg
- SEVRE-LONG prolonged-release capsule, hard 60 mg
- TARGIN prolonged-release tablet 10 mg+5 mg
- TARGIN prolonged-release tablet 20 mg+10 mg
- TARGIN prolonged-release tablet 40 mg+20 mg
- TARGIN prolonged-release tablet 5 mg+2.5 mg
- TARGIN prolonged-release tablet 60 mg+30 mg
- TARGIN prolonged-release tablet 80 mg+40 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLUTIFORM pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- UNIFYL CONTINUS prolonged-release tablet 200 mg
- UNIFYL CONTINUS prolonged-release tablet 400 mg
- UNIFYL CONTINUS prolonged-release tablet 600 mg